Dendritic cells fused with allogeneic hepatocellular carcinoma cell line compared with fused autologous tumor cells as hepatocellular carcinoma vaccines

Hepatology Research

Volumn 40, Issue 5, 2010, Pages 505-513

  Yang, Jing Yue ^a   Cao, Da Yong ^b   Ma, Long Yang ^b   Liu, Wen Chao ^a  

^a Department of Physiology   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Allogeneic; BEL7402; Cytotoxic T lymphocytes; Dendritic cells; Immunotherapy

Indexed keywords

ALPHA FETOPROTEIN; ALPHA INTERFERON; DENDRITIC CELL VACCINE; HLA A2 ANTIGEN; HLA DR ANTIGEN; TUMOR ANTIGEN; TUMOR CELL VACCINE;

ADULT; ALLOGENEIC RESTRICTION; ANTIGEN EXPRESSION; ARTICLE; CANCER CELL DESTRUCTION; CASE REPORT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL KILLING; CELL MEDIATED CYTOTOXICITY; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; ELECTROFUSION (CELL); FEMALE; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; LYMPHOCYTE PROLIFERATION; MALE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

EID: 77954373047     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2010.00625.x     Document Type: Article

References (28)

1. Hussain K, El-Serag HB. Epidemiology, screening, diagnosis and treatment of hepatocellular carcinoma. Minerva Gastroenterol Dietol 2009, 55:123-38.
2. Butterfield LH, Ribas A, Dissette VB, Lee Y. A Phase I/II trial testing immunization of hepatocellular carcinoma patients with dendritic cells pulsed with four α-fetoprotein peptides. Clin Cancer Res 2006, 12:2817-25.
3. Cao DY, Yang JY, Dou KF, Ma LY, Teng ZH. alpha-fetoprotein and interleukin-18 gene-modified dendritic cells effectively stimulate specific type-1 CD4- and CD8-mediated T-Cell response from hepatocellular carcinoma patients in Vitro. Hum Immunol 2007, 68:334-41.
4. Yang JY, Cao DY, Liu WC, Zhang HM, Teng ZH, Ren J. Dendritic cell generated from CD34+ hematopoietic progenitors can be transfected with adenovirus containing gene of HBsAg and induce antigen-specific cytotoxic T-cell responses. Cell Immunol 2006, 240:14-21.
5. Kim GY, Chae HJ, Kim KH. Dendritic cell-tumor fusion vaccine prevents tumor growth in vivo. Biosci Biotechnol Biochem 2007, 71:215-21.
6. Chan RC, Xie H, Zhao GP, Xie Y. Dendritomas formed by fusion of mature dendritic cells with allogeneic human hepatocellular carcinoma cells activate autologous cytotoxic T lymphocytes. Immunol Lett 2002, 83:101-9.
7. Schoeters E, Verheyen GR, Van Den Heuvel R. Expression analysis of immune-related genes in CD34(+) progenitor-derived dendritic cells after exposure to the chemical contact allergen DNCB. Toxicol In Vitro 2005, 19:909-13.
8. Boon T, Van der Bruggen P. Human tumor antigens recognized by T lymphocytes. J Exp Med 1996, 183:725-9.
9. Gong J, Chen D, Kashiwaba M, Kufe D. Induction of antitumor activity by immunization with fusions of dendritic and carcinoma cells. Nat Med 1997, 3:558-61.
10. Gong J, Nikrui N, Chen D. Fusions of human ovarian carcinoma cells with autologous or allogeneic dendritic cells induce antitumor immunity. J Immunol 2000, 165:1705-11.
11. Koido S, Tanaka Y, Chen D, Kufe D, Gong J. The kinetics of in vivo priming of CD4 and CD8 T-cells by dendritic/tumor fusion cells in MUC1-transgenic mice. J Immunol 2002, 168:2111-17.
12. Trefzer U, Weingart G, Chen Y. Hybrid cell vaccination for cancer immune therapy: first clinical trial with metastatic melanoma. Int J Cancer 2000, 85:618-26.
13. Shi M, Su L, Hao S, Guo X, Xiang J. Fusion hybrid of dendritic cells and engineered tumor cells expressing interleukin-12 induces type 1 immune responses against tumor. Tumori 2005, 91:531-8.
14. Homma S, Kikuchi T, Ishiji N. Cancer Immunotherapy by fusion of dendritic and tumor cells and rh-IL-12. Eur J Clin Invest 2005, 35:279-86.
15. Trevor KT, Cover C, Ruiz YW. Generation of dendritic cell-tumor cell hybrids by electrofusion for clinical vaccine application. Cancer Immunol Immunother 2004, 53:705-14.
16. Homma S, Sagawa Y, Ito M, Ohno T, Toda G. Cancer immunotherapy using dendritic/tumour-fusion vaccine induces elevation of serum anti-nuclear antibody with better clinical responses. Clin Exp Immunol 2006, 144:41-7.
17. Liu L, Chahroudi A, Silvestri G. Visualization and quantification of T-cell-mediated cytotoxicity using cell-permeable fluorogenic caspase substrates. Nat Med 2002, 8:185-9.
18. Rosenblatt J, Kufe D, Avigan D. Dendritic cell fusion vaccines for cancer immunotherapy. Expert Opin Biol Ther 2005, 5:703-15.
19. Yasuda T, Kamigaki T, Nakamura T. Dendritic cell-tumor cell hybrids enhance the induction of cytotoxic T lymphocytes against murine colon cancer: a comparative analysis of antigen loading methods for the vaccination of immunotherapeutic dendritic cells. Oncol Rep 2006, 16:1317-24.
20. Jantscheff P, Spagnoli G, Zajac P. Cell fusion: an approach to generating constitutively proliferating human tumor antigen-presenting cells. Cancer Immunol Immunother 2002, 51:367-75.
21. Shu S, Cohen P. Tumor-dendritic cell fusion technology and immunotherapy strategies. J Immunother 2001, 24:99-100.
22. Kumagi T, Akbar SM, Horiike N. Administration of dendritic cells in cancer nodules in hepatocellular carcinoma. Oncol Rep 2005, 14:969-73.
23. Höltl L, Ramoner R, Zelle-Rieser C. Allogeneic dendritic cell vaccination against metastatic renal cell carcinoma with or without cyclophosphamide. Cancer Immunol Immunother 2005, 54:663-70.
24. Ovali E, Dikmen T, Sonmez M. Active immunotherapy for cancer patients using tumor lysate pulsed dendritic cell vaccine: a safety study.J Exp. Clin Cancer Res 2007, 26:209-14.
25. Ishida A, Tanaka H, Hiura T. Generation of anti-tumour effector T-cells from naïve T-cells by stimulation with dendritic/tumour fusion cells.Scand. J Immunol 2007, 66:546-54.
26. Jerome KR, Sloan DD, Aubert M. Measuring T-cell-mediated cytotoxicity using antibody to activated caspase 3. Nat Med 2003, 9:4-5.
27. Koido S, Tanaka Y, Tajiri H, Gong J. Generation and functional assessment of antigen-specific T-cells stimulated by fusions of dendritic cells and allogeneic breast cancer cells. Vaccine 2007, 25:2610-19.
28. Koido S, Hara E, Homma S, Torii A, Toyama Y, Kawahara H, Watanabe M, Yanaga K, Fujise K, Tajiri H, Gong J, Toda G. Dendritic cells fused with allogeneic colorectal cancer cell line present multiple colorectal cancer-specific antigens and induce antitumor immunity against autologous tumor cells. Clin Cancer Res 2005, 11:7891-900.